ERCP Voices of Experience Series, Part-4, Endoscopic Biliary Stenting: Optimizing Technique, Improving Outcomes, and Avoiding Pitfalls
In Part 4 of ERCP Voices of Experience, Dr. David Diehl and Dr. Todd Baron explore endoscopic biliary stenting, emphasizing clinical indications, stent selection, and best practices. The experts discuss stenting advantages between plastic vs metal stents, including the advantages of fully covered metal stents for malignancies. They address complex scenarios like high-risk strictures, cystic duct leaks, and pancreatic cancer. Hear strategies on the management of chronic pancreatitis, the use of double pigtail stents, and the challenges of transpapillary gallbladder drainage.
ERCP Voices of Experience, ERCP, biliary stenting, stent selection, best practices and techniques for safe and effective stent placement. clinical case reviews, David Diehl, Todd Baron, Endoscopic Biliary Stenting, Olympus, chronic pancreatitis, fully covered metal stents, FCMS, cystic duct, cystic duct leak, pancreatic cancer, MRCP, biliary strictures, Viabil, VirtualED, transpapillary gallbladder drainage, PSC, primary sclerosing cholangitis, cholangitis, cholecystitis, cholangiocarcinoma, plastic vs metal stent
Other Featured Videos
Consensus, Collaboration, and Care: Redefining Acute Cholecystitis
October 23, 2025
Boston Scientific EDUCARE
Drs. Todd Baron, Ahsun Diaz, and Patrick Murphy explore solutions for acute cholecystitis from a multidisciplinary perspective. How would a gastroenterologist, a surgeon, and an interventional radiologist tackle cholecystitis management and what treatments would be recommended? See several case examples that outline options available and the complexity of acute cholecystitis care, including variability involved on a patient-by-patient basis.
Clinical Practice Model - Transoral Incisionless Fundoplication (TIF 2.0®): Exploring New Paradigms of GI and Surgeon Collaboration
April 22, 2026
ENow Solutions
Key opinion leaders discuss Transoral Incisionless Fundoplication (TIF 2.0®) and its clinical practice model. Key points included the importance of patient selection, using the American Foregut Society's endoscopic rate of the GEJ to grade patients, and selecting suitable candidates for TIF or combined approaches. Complications such as perforation, bleeding, and mucosal lacerations were addressed, with emphasis on early detection and management. Long-term outcomes showed significant symptom relief and PPI discontinuation in over 70% of patients, with durability up to 10 years. Hear how to navigate the intricacies of incorporating TIF 2.0® into your practice.
Endoscopic Eradication Therapy 20 Years Later: Have we made a Difference? An Update in Screening, Surveillance, and Therapy of Barrett's Esophagus and Early EAC
April 10, 2025
Medtronic
Dr. Sri Komanduri covers a review of the 20 year history of endoscopic eradication therapy including current novel innovation for screening and surveillance for Barrett’s esophagus and esophageal adenocarcinoma. See where we’ve been - and where we are going - with BE/EAC patient care.
